Drug intelligence / Profile preview

MacularProtect Plus

Development stage
Unknown
Lead developer
ScienceBased Health
Modality
Small Molecules
Administration
Oral
01

Overview

MacularProtect Plus is a high-potency dietary supplement designed to support ocular health and provide comprehensive nutritional coverage. It is specifically formulated based on the findings of the Age-Related Eye Disease Study 2 (AREDS2), incorporating clinical doses of lutein (10 mg), zeaxanthin (2 mg), vitamin C, vitamin E, zinc, and copper. Beyond its primary role in supporting the macula and reducing the risk of progression in patients with intermediate to advanced age-related macular degeneration (AMD), the "Plus" designation indicates the inclusion of a full multivitamin and mineral profile. This integrated approach provides over 30 additional nutrients, including B-vitamins, antioxidants like alpha-lipoic acid and taurine, and essential minerals, eliminating the need for patients to take a separate daily multivitamin. The product is developed and marketed by ScienceBased Health.

Brand names
MacularProtect Plus
02

Targets

Misfolded SOD1

Beyond the preview

Go deeper on MacularProtect Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MacularProtect Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call